Dr. Peti Vainio to become Executive ChairmanDr. Evis Hursever to become CEOScott Barry to become COOMarty Sutter to become Founding PartnerNEW YORK, NY / ACCESSWIRE / November 18, 2024 / EW Healthcare ...

Program Will Focus on Supporting the Health and Careers of Women in Midlife WASHINGTON, DC / ACCESSWIRE / November 18, 2024 / Menopause and perimenopause are pivotal life stages that can profoundly ...

LAVAL, QC / ACCESSWIRE / November 18, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), today announced the first look at ...

Advancements Enhance Efficacy in Hypha's Revolutionary Home and Commercial Production UnitsLAS VEGAS, NV / ACCESSWIRE / November 18, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional ...

Dr. Petri Vainio to become Executive ChairmanDr. Evis Hursever to become CEOScott Barry to become COOMarty Sutter to become Founding PartnerNEW YORK, NY / ACCESSWIRE / November 18, 2024 / EW ...

Ipsen presents three late-breaking presentations and eight abstracts across rare cholestatic liver disease portfolio at AASLD 2024Elafibranor was granted marketing authorisation for the treatment of ...

Healthcare communications agency ZPB Associates has expanded its senior team by adding Dr Arvind Madan and Dr Jenny Shand as new Senior Associates. The appointments are expected to strengthen ZPB’s ...

KANSAS CITY, KS / ACCESSWIRE / November 18, 2024 / Glow Sauna Studios, a recognized leader in holistic wellness, is pleased to announce a new multi-unit agreement, in Metro Kansas City, with the first ...

MELBOURNE, AUSTRALIA / ACCESSWIRE / November 18, 2024 / Immuron Limited (NASDAQ:IMRN) has one commercial product and two pipeline assets in three clinical programs for the treatment of gut mediated ...

In the ever-evolving world of pharmaceutical development, the quest to innovate and improve the delivery of drug substances remains a top priority. Among the many formulation strategies, oral liquid ...

Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines, wishes to provide an update on its ...

Quell Therapeutics Ltd (“Quell”), a leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, announces that AstraZeneca has ...